Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0000950123-06-003601
Filing Date
2006-03-23
Accepted
2006-03-23 17:24:54
Documents
6
Period of Report
2005-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K y18060a1e10vkza.htm 10-K/A 1477196
2 EX-23: CONSENT OF KPMG LLP y18060a1exv23.txt EX-23 2204
3 EX-31.1: CERTIFICATION y18060a1exv31w1.htm EX-31.1 7995
4 EX-31.2: CERTIFICATION y18060a1exv31w2.htm EX-31.2 8012
5 EX-32.1: CERTIFICATION y18060a1exv32w1.htm EX-32.1 3966
6 EX-32.2: CERTIFICATION y18060a1exv32w2.htm EX-32.2 4020
  Complete submission text file 0000950123-06-003601.txt   1504885
Mailing Address 41 PINELAWN ROAD MELVILLE NY 11747
Business Address 41 PINELAWN ROAD MELVILLE NY 11747 631-962-2000
OSI PHARMACEUTICALS INC (Filer) CIK: 0000729922 (see all company filings)

EIN.: 133159796 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 000-15190 | Film No.: 06706946
SIC: 2835 In Vitro & In Vivo Diagnostic Substances